August 5, 2024
To | To |
Listing Department, | The Corporate Relations Department |
NATIONAL STOCK EXCHANGE OF INDIA LIMITED | BSE LIMITED |
Exchange Plaza, | Phiroz Jeejeebhoy Towers, |
Bandra Kurla Complex, Bandra (E), | 25th floor, Dalal Street, |
MUMBAI -400 051 | MUMBAI -400 001 |
Company Code No. AUROPHARMA | Company Code No. 524804 |
Dear Sir/Madam,
Sub: Analyst / Investor call
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the schedule of Earnings Call to be held on August 12, 2024, at 8:30 AM (IST) on Unaudited Financial Results of the Company for the first quarter ended June 30, 2024.
Thanking you,
Yours faithfully,
For AUROBINDO PHARMA LIMITED
BADDIGAM ADI REDDY
B. Adi Reddy
Company
Encl: as above
Digitally signed by
BADDIGAM ADI REDDY
Date: 2024.08.05 10:11:37 +05'30'
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad - 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: PlotNo. 2, Maithrivihar, Ameerpet, Hyderabad - 500038 T.S., INDIA Tel:+91 4023736370/ 23747340 Fax: +914023741080 / 23746833 Email: info@aurobindo.com Website: www.aurobindo.com